Sanofi Is Looking at US Biotech Acquisitions -Bloomberg
July 17 2020 - 1:29AM
Dow Jones News
--Sanofi SA is looking at potential U.S. biotech acquisitions as
it seeks to expand its work in multiple sclerosis and immune
disorders, Bloomberg reports, citing unnamed sources.
--One of the targets being studied by the French company is
Pricipia Biopharma Inc., Bloomberg reports.
Full story: https://bloom.bg/2CF0OYj
Write to Barcelona editors at barcelonaeditors@dowjones.com
(END) Dow Jones Newswires
July 17, 2020 02:14 ET (06:14 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Apr 2024 to May 2024
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From May 2023 to May 2024